Topic: Cardiovascular Safety of Testosterone-Replacement Therapy

Objective(s): In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events. (Funded by AbbVie and others; TRAVERSE ClinicalTrials.gov number, NCT03518034.)

Speaker: Dr. Kyle Horton

Session date: 
08/08/2023 - 7:00am to 8:00am EDT
Location: 
iTOR Bright Conference Room
701 Grove Road
Greenville, SC 29605
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register to take this course.